AR

ALEXANDER ROOT

THE KPM GROUP DC LLC · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
5
last 3 years
Filings
7
2 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Washington, DC
2024 - present

Specific issues

H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 5539, ORPHAN Cures Act H.R. 4408/S.1644, Promising Pathway Act S.4426,Promising Pathway Act 2.0 H.R. 3100, Sickle Cell Care Expansion Act of 2023
Pharmacy · 2024 Q3
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R.7384/S.4583, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act H.R.8702/S.4532, Improving Seniors Timely Access to Care Act of 2024 S.4905, Innovation in Pediatric Drugs Act H.R.4758/S.2372, Accelerating Kids Access to Care Act
Pharmacy · 2024 Q3
H.R. 7384, Creating Hope Reauthorization Act S. 4426, Promising Pathway Act 2.0
Pharmacy · 2024 Q2
H.R.6664 - Innovation in Pediatric Drugs Act of 2023 H.R.7384 - Creating Hope Reauthorization Act of 2024 H.Res.1307 - Expressing support for the designation of June 20, 2024, as "World FSHD Day". H.R. 7432, Sickle Cell Disease Comprehensive Care Act H.R. 7384, Creating Hope Reauthorization Act of 2024 S. 652, Safe Step Act H.R.1092, Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 S. 1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 H.R. 830/S. 1375, HELP Copays Act H.R. 883/S. 320, Stop the Wait Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act H.R. 6094, Providing Realistic Opportunity To Equal and Comparable Treatment for (PROTECT) Rare Act
Pharmacy · 2024 Q2
H.R. 830/S. 1375, HELP Copays Act H.R. 2630/S. 652, Safe Step Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R.5539/S.3131, ORPHAN Cures Act H.R.7384, the Creating Hope Reauthorization Act of 2024 H.R.4408/S.1906, Promising Pathway Act
Pharmacy · 2024 Q2
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Rare Disease Drug Development Ultra-Rare Disease Definition
Pharmacy · 2024 Q1

Clients

2024 · 2 filings
$██,███ / qtrUnlock
$██,███ / qtrUnlock
2024 · 1 filing
$██,███ / qtrUnlock
$██,███ / qtrUnlock
$██,███ / qtrUnlock

Filing history

2024 Q3
FULCRUM THERAPEUTICS, INC.
Q3lda.gov →
2024 Q3
ASTRIA THERAPEUTICS, INC.
Q3lda.gov →
2024 Q2
SOLENO THERAPEUTICS, INC.
Q2lda.gov →
2024 Q2
FULCRUM THERAPEUTICS, INC.
Q2lda.gov →
2024 Q2
ASTRIA THERAPEUTICS, INC.
Q2lda.gov →
2024 Q1
STEALTH BIOTHERAPEUTICS INC.
1Tlda.gov →
2024 Q1
REZOLUTE
Q1lda.gov →
Showing recent filings · full history on lda.gov